Skip to main content

Advertisement

SpringerLink
Log in

Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Recurrence of focal glomerulosclerosis (FSGS) following renal transplantation is a common cause of allograft loss and clinical morbidity. Recent attempts to control proteinuria and morbidity with plasmapheresis (PP) have met with limited success. Our experience with the use of mycophenolate mofetil (MMF) and angiotensin blockade (AB) in the management of refractory FSGS pre transplant suggested its potential benefit in post-transplant recurrence. This report presents our 25-year experience in pediatric renal transplantation of patients with FSGS divided into two treatment eras: Era 1—prior to use of daclizumab (anti-IL-2R) and Era 2—after daclizumab. A total of 179 pediatric patients were transplanted during the 25-year period. FSGS was confirmed in 27 (15%); 16 of 28 allografts (57%) had recurrence of FSGS during the post-transplant period. In Era 1, only 6 of 16 (38%) recurred in the allograft, while 10 of 12 (83%) recurred during Era 2. The odds ratio of recurrence of FSGS in the allograft after induction with anti-IL-2R was 8.3 (95% confidence interval=1.3–52, P =0.02). Only 2 patients in Era 1 received PP, while 10 in Era 2 were entered into an intensive PP protocol followed by maintenance with AB consisting of angiotensin receptor blockers alone, or in combination with angiotensin-converting enzyme inhibitor. Although proteinuria decreased an average of 80±16% with PP, the response was variable and severe morbid edema persisted in poor responders. Maximum benefit occurred with the addition of AB and MMF. After a follow-up of 27±15 months, proteinuria has shown a sustained decrease of 94±8% below baseline. In conclusion, our experience suggests that, with recurrent FSGS, a limited course of PP followed by maintenance therapy with AB and MMF improves symptoms and may preserve allograft function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Dall’Amico R, Ghiggeri G, Carraro M, Artero M, Ghio L, Zamorani E, Zennaro C, Basile G, Montini G, Rivabella L, Cardillo M, Scalamogna M, Ginevri F (1999) Prediction and treatment of recurrent FSGS after renal transplantation in children. Am J Kidney Dis 34:1048–1055

    PubMed  Google Scholar 

  2. Benfield M, McDonald R, Sullivan E, Stablein D, Tejani A (1999) The 1997 annual renal transplantation in children: Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 3:152–167

    Article  CAS  PubMed  Google Scholar 

  3. Sharma M, Sharma R, McCarthy E, Savin V (1999) “The FSGS factor”: enrichment in vivo effect of activity from focal segmental glomerulosclerosis plasma. J Am Soc Nephrol 10:552–561

    CAS  PubMed  Google Scholar 

  4. Savin V, Sharma R, Sharma M, McCarthy E, Swan U, Ellis E, Lovell H, Warady B, Gunwar R, Chonko A, Artero M, Vincenti F (1996) Circulating factor with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334:878–883

    Article  CAS  PubMed  Google Scholar 

  5. Greenstein S, Delrio M, Ong E, Feuerstein D, Schechner R, Kim D, Corey H, Kaskel R, Tellis V, Moritz M (2000) Plasmapheresis treatment for recurrent focal sclerosis in pediatric renal allografts. Pediatr Nephrol 14:1061–1065

    Article  CAS  PubMed  Google Scholar 

  6. Ohta T, Kawaguchi H, Hattori M, Komatsu Y, Akioka Y, Nagata M, Shiraga H, Ito K, Takahashi K, Ishikawa N, Tanabe K, Yamaguchi Y, Ota K (2001) Effect of pre and postoperative plasmapheresis on posttransplant recurrence of FSGS in children. Transplantation 71:628–633

    Article  CAS  PubMed  Google Scholar 

  7. Belson A, Yorgin P, Al-Uzri A, Salvatierra O, Higgins J, Alexander S (2001) Long term plasmapheresis and protein A column treatment of recurrent FSGS. Pediatr Nephrol 16:985–989

    Article  CAS  PubMed  Google Scholar 

  8. Montane B, Abitbol C, Chandar J, Strauss J, Zilleruelo G (2003) Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockade. Pediatr Nephrol 18:772–777

    Article  PubMed  Google Scholar 

  9. Abitbol C, Burke G, Zilleruelo G, Montane B, Strauss J (1991) Clinical management of the pediatric renal-allograft recipient. Child Nephrol Urol 11:169–178

    CAS  PubMed  Google Scholar 

  10. Ciancio G, Burke G, Suzart K, Mattiazzi A, Rosen A, Zilleruelo G, Abitbol C, Montane B, Miller J (2002) Effect of daclizumab, tacrolimus and mycophenolate mofetil in pediatric first renal transplant recipients. Transplant Proc 34:1944–1945

    Article  CAS  PubMed  Google Scholar 

  11. Ettenger R, Mentser M, Warshaw B (1999) The long-term use of mycophenolate mofetil in pediatric renal transplantation: a report of the pediatric mycophenolate mofetil study group. Transplantation 67:S118

    Google Scholar 

  12. International Study of Kidney Disease in Children (1981) The primary nephrotic syndrome. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 98:561–564

    PubMed  Google Scholar 

  13. Tarshish P, Tobin J, Bernstein J, Edelman C (1996) Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. Pediatr Nephrol 10:590–593

    Article  CAS  PubMed  Google Scholar 

  14. Abitbol C, Zilleruelo G, Freundlich M, Strauss J (1990) Quantification of proteinuria with urinary protein/creatinine ratios and random testing with dipsticks in nephrotic syndrome. J Pediatr 116:243–247

    CAS  PubMed  Google Scholar 

  15. Motulsky H (1995) Intuitive biostatistics, 2nd edn. Oxford University Press, New York, pp 207–262

  16. Raafat R, Travis L, Kalia A, Diven S (2000) Role of transplant induction therapy on recurrence rate of focal segmental glomerulosclerosis. Pediatr Nephrol 14:189–194

    Article  CAS  PubMed  Google Scholar 

  17. Sheth R, Kale A, Goldstein S, Brewer E (2001) Rapid recurrence of post-transplant FSGS in pediatric patients after daclizumab induction. Pediatr Nephrol 16:C190

    Article  Google Scholar 

  18. Gagnadoux MF (2002) Does antibody induction therapy with daclizumab or basiliximab increase the risk of recurrence of post-transplant focal segmental glomerulosclerosis? Pediatr Nephrol 17:305

    Article  PubMed  Google Scholar 

  19. Grimbert P, Audard V, Remy P, Lang P, Sahali D (2003) Recent approaches to the pathogenesis of minimal-change nephrotic syndrome. Nephrol Dial Transplant 18:245–248

    Google Scholar 

  20. Baum M, Stablein D, Panzarino V, Tejani A, Harmon W, Alexander S (2001) Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis. Kidney Int 59:328–333

    Article  CAS  PubMed  Google Scholar 

  21. Briggs W, Choi M, Scheel P (1998) Successful mycophenolate mofetil treatment of glomerular disease. Am J Kidney Dis 31:213–217

    CAS  PubMed  Google Scholar 

  22. Fujihara C, De L, Malheiros I, Antunes G, Oliveira I, Zatz R (2000) Combined mycophenolate mofetil and losartan therapy arrests established injury in the remnant kidney. J Am Soc Nephrol 11:283–290

    CAS  PubMed  Google Scholar 

  23. Stigant C, Cohen J, Vivera M, Zaltsman J (2000) ACE inhibitors and angiotensin II antagonist in renal transplantation: an analysis of safety and efficacy. Am J Kidney Dis 35:58–63

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported in part by a grant from Children’s Medical Services, Florida’s Department of Health.

Author information

Authors and Affiliations

  1. Division of Pediatric Nephrology, Holtz Children’s Hospital, University of Miami, P.O. Box 016960 (M-714), Miami, FL 33101, USA

    Hans Hubsch, Brenda Montané, Carolyn Abitbol, Jayanthi Chandar, José Strauss & Gastón Zilleruelo

  2. Division of Transfusion Services, Holtz Children’s Hospital, University of Miami, P.O. Box 016960 (M-714), Miami, FL 33101, USA

    Sherry Shariatmadar

  3. Division of Renal Transplantation, Holtz Children’s Hospital, University of Miami, P.O. Box 016960 (M-714), Miami, FL 33101, USA

    Gaetano Ciancio, George Burke & Joshua Miller

Authors
  1. Hans Hubsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brenda Montané
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carolyn Abitbol
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jayanthi Chandar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sherry Shariatmadar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gaetano Ciancio
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. George Burke
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Joshua Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. José Strauss
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Gastón Zilleruelo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gastón Zilleruelo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hubsch, H., Montané, B., Abitbol, C. et al. Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience. Pediatr Nephrol 20, 210–216 (2005). https://doi.org/10.1007/s00467-004-1706-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-004-1706-7

Keywords

Search

Navigation